European CHMP recommends approval of licence extension of clopidogrel (Plavix)

The licence extension, in combination with acetylsalicylic acid, is for adults with moderate to high-risk TIA (ABCD2 score ≥4) or minor IS (NIHSS ≤3) within 24 hours of either the TIA or IS event.

Source:

European Medicines Agency